Form 4 Tracker
SUPERNUS PHARMACEUTICALS, INC.
SUPN

34 insider filings · Latest: Mar 16, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 18, 2026Mar 18 9:18 PMPadmanabh P. BhattSr. VP of IP, CSO
Sale
7,250$49.60$359.6K17,044(D)

View →

Mar 17, 2026Mar 18 9:18 PMPadmanabh P. BhattSr. VP of IP, CSO
Sale
50,000$50.30$2.5M17,044(D)

View →

Mar 16, 2026Mar 18 9:18 PMPadmanabh P. BhattSr. VP of IP, CSO
Sale
50,000$50.28$2.5M17,044(D)

View →

Mar 17, 2026Mar 17 8:29 PMPADMANABH P BHATT
Proposed Sale
57,250$50.21$2.9M

View →

Mar 16, 2026Mar 16 8:38 PMPADMANABH P BHATT
Proposed Sale
50,000$49.91$2.5M

View →

Mar 13, 2026Mar 16 8:08 PMJack A. KhattarDirector, President, CEO
Sale
35,000$50.37$1.8M958,100(I)

View →

Mar 12, 2026Mar 16 8:07 PMFrederick M. HudsonDirector
Sale
5,369$50.61$271.7K60,413(D)

View →

Mar 13, 2026Mar 13 8:22 PMTHE KBT TRUST U/A DTD 12/30/2010
Proposed Sale
35,000$50.46$1.8M

View →

Mar 12, 2026Mar 12 8:06 PMFREDERICK M HUDSON
Proposed Sale
5,369$50.62$271.8K

View →

Mar 10, 2026Mar 10 8:18 PMWILLIAM TODD HORICH
Proposed Sale
4,439$55.00$244.1K

View →

Mar 9, 2026Mar 10 8:13 PMFrank MottolaSVP, Chief Tech. Ops. Officer
Sale
1,623$53.65$87.1K18,440(D)

View →

Mar 10, 2026Mar 10 8:12 PMWilliam Todd HorichSVP, Commercial Operations
Sale
4,439$55.00$244.1K0(D)

View →

Mar 9, 2026Mar 10 8:12 PMWilliam Todd HorichSVP, Commercial Operations
Sale
4,438$54.00$239.7K4,439(D)

View →

Mar 9, 2026Mar 9 8:43 PMWILLIAM TODD HORICH
Proposed Sale
4,438$54.00$239.7K

View →

Mar 9, 2026Mar 9 8:16 PMFRANK MOTTOLA
Proposed Sale
1,623$53.65$87.1K

View →

Mar 6, 2026Mar 9 8:06 PMGeorges GemayelDirector
Sale
8,787$53.00$465.7K27,277(D)

View →

Mar 5, 2026Mar 9 8:06 PMGeorges GemayelDirector
Sale
10,000$53.71$537.1K28,159(D)

View →

Mar 6, 2026Mar 6 9:24 PMGEORGES GEMAYEL
Proposed Sale
8,787$53.01$465.8K

View →

Mar 5, 2026Mar 5 9:04 PMGEORGES GEMAYEL
Proposed Sale
10,000$53.71$537.1K

View →

Feb 19, 2026Feb 23 9:39 PMBethany SensenigDirector
Sale
4,475$51.01$228.3K0(D)

View →

Page 1 of 3

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 24, 2026Feb 25 9:54 PMFrank MottolaSVP, Chief Tech. Ops. Officer
Disposition
3,1252,500(D)

View →

Feb 24, 2026Feb 25 9:51 PMJonathan RubinSVP, Chief Medical Officer
Disposition
3,1252,500(D)

View →

Feb 24, 2026Feb 25 9:36 PMGeorges GemayelDirector
Disposition
4,4750(D)

View →

Feb 23, 2026Feb 25 9:36 PMGeorges GemayelDirector
Option Exercise
15,000$12.980(D)

View →

Feb 19, 2026Feb 23 9:39 PMBethany SensenigDirector
Option Exercise
4,4750(D)

View →

Feb 18, 2026Feb 20 9:49 PMTimothy C DecSenior Vice-President & CFO
Grant/Award
20,500$50.203,000(D)

View →

Feb 18, 2026Feb 20 9:48 PMPadmanabh P. BhattSr. VP of IP, CSO
Grant/Award
16,500$50.203,000(D)

View →

Feb 18, 2026Feb 20 9:47 PMJonathan RubinSVP, Chief Medical Officer
Grant/Award
16,500$50.203,000(D)

View →

Feb 18, 2026Feb 20 9:46 PMFrank MottolaSVP, Chief Tech. Ops. Officer
Grant/Award
16,500$50.203,000(D)

View →

Feb 18, 2026Feb 20 9:46 PMJack A. KhattarDirector, President, CEO
Grant/Award
341,610$50.20341,610(D)

View →

Feb 18, 2026Feb 20 9:45 PMGeorges GemayelDirector
Grant/Award
7,966$50.204,977(D)

View →

Feb 18, 2026Feb 20 9:44 PMCarrolee BarlowDirector
Grant/Award
7,966$50.204,977(D)

View →

Feb 18, 2026Feb 20 9:43 PMBethany SensenigDirector
Grant/Award
7,966$50.204,977(D)

View →

Feb 18, 2026Feb 20 9:40 PMCharles W Newhall IIIDirector
Grant/Award
7,966$50.204,977(D)

View →

Feb 18, 2026Feb 20 9:39 PMFrederick M. HudsonDirector
Grant/Award
7,966$50.204,977(D)

View →

← Previous

Page 2 of 2